Company Filing History:
7 out of 3,684 
2 out of 144 
1 out of 560 
Years Active: 1995-2017
Title: The Innovative Journey of Douglas James Riexinger
Introduction: Douglas James Riexinger, based in Flemington, NJ, is a remarkable inventor known for his contributions to the field of pharmacology and receptor biology. With a total of nine patents to his name, Riexinger has significantly advanced the understanding and application of protease activated receptor 4 (PAR4) agonist peptides.
Latest Patents: Among his latest innovations, Riexinger has developed crucial PAR4 agonist peptides. These peptides are essential for creating robust assays for the PAR4 receptor, facilitating advancements in pharmacological research and therapeutic applications. Notably, the present invention showcases a new collection of PAR4 agonist peptides, further establishing Riexinger's role in innovating within this vital area of health science.
Career Highlights: Riexinger has had a fruitful career, most notably working with prestigious companies in the biotech and pharmaceutical industries. His experience includes tenures at Bristol-Myers Squibb Company and Centocor, Inc., where he honed his skills and expertise in drug development and receptor research.
Collaborations: Throughout his career, Riexinger has collaborated with esteemed colleagues, including Claudio Mapelli and Ving G. Lee. These partnerships have propelled his research forward, leading to groundbreaking inventions that enhance the understanding of receptor mechanisms and their potential therapeutic implications.
Conclusion: Douglas James Riexinger's dedication to innovation in the realm of PAR4 receptor research underscores his status as a leading inventor. His contributions, marked by a series of nine patents, continue to influence the fields of pharmacology and biotechnology, paving the way for future discoveries and advancements.